$DOVP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Euthymics Bioscience, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Euthymics Bioscience, Inc.. Get notifications about new insider transactions in Euthymics Bioscience, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.00 | 772,327 | 2,317 | 1,509,292 | 737 K to 1.5 M (+104.80 %) |
Oct 08 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 125,000 | 5,000 | 736,702 | 611.7 K to 736.7 K (+20.43 %) |
Sep 15 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 16,500 | 611 | 611,702 | 595.2 K to 611.7 K (+2.77 %) |
Sep 15 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 10,000 | 370 | 595,202 | 585.2 K to 595.2 K (+1.71 %) |
Sep 09 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 1,330 | 49 | 585,202 | 583.9 K to 585.2 K (+0.23 %) |
Sep 09 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 51,500 | 1,906 | 583,872 | 532.4 K to 583.9 K (+9.67 %) |
Sep 09 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 7,051 | 261 | 532,372 | 525.3 K to 532.4 K (+1.34 %) |
Sep 02 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 200,000 | 7,000 | 525,321 | 325.3 K to 525.3 K (+61.48 %) |
Jul 18 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 10,495 | 378 | 225,321 | 214.8 K to 225.3 K (+4.89 %) |
Jul 01 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 75,826 | 2,730 | 214,826 | 139 K to 214.8 K (+54.55 %) |
Jul 01 2008 | DOVP | Euthymics Bioscien ... | Zakrzewski Joseph S | Director | Buy | P | 0.04 | 1,000 | 36 | 139,000 | 138 K to 139 K (+0.72 %) |
May 20 2008 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | D | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | D | 0.00 | 407,600 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Option Exercise | D | 0.00 | 184,150 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Option Exercise | D | 0.00 | 127,000 | 0 | 127,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | D | 0.00 | 216,300 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Option Exercise | A | 0.00 | 127,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Option Exercise | A | 0.00 | 260,000 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Option Exercise | D | 0.00 | 248,200 | 0 | 387,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 500,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 500,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 500,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 635,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 740,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.00 | 560,000 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | D | 0.00 | 5,821,209 | 0 | 3,435,000 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 550,000 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 550,000 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 550,000 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 698,500 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 724,500 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.00 | 705,500 | 0 | 3,778,500 | |
May 20 2008 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | Director | Option Exercise | D | 0.00 | 5,830,709 | 0 | 3,778,500 | |
Apr 08 2008 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | P | 0.05 | 100,000 | 5,300 | 138,000 | 38 K to 138 K (+263.16 %) |
Jan 17 2008 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | P | 0.07 | 13,800 | 966 | 38,700 | 24.9 K to 38.7 K (+55.42 %) |
Sep 10 2007 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | P | 0.20 | 25,000 | 5,000 | 25,000 | 0 to 25 K |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Skolnick Phil | President and CSO | Option Exercise | A | 0.33 | 5,031,209 | 1,660,299 | 5,821,209 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | CEO | Option Exercise | A | 0.33 | 5,031,209 | 1,660,299 | 5,830,709 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 184,150 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 216,300 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 407,600 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Lippa Arnold | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 248,200 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 127,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Option Exercise | A | 0.30 | 127,000 | 38,100 | 127,000 | |
Aug 13 2007 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jun 20 2007 | DOVP | Euthymics Bioscien ... | UBS AG | Sell | J | 0.00 | 2,500,000 | 0 | 9,725,672 | 12.2 M to 9.7 M (-20.45 %) | |
Jun 13 2007 | DOVP | Euthymics Bioscien ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Option Exercise | C | 0.00 | 13,295,418 | 0 | 0 | |
Jun 13 2007 | DOVP | Euthymics Bioscien ... | HIGHBRIDGE CAPITAL MANAGEMENT ... | 10% Owner | Buy | C | 0.00 | 13,295,418 | 0 | 13,295,418 | 0 to 13.3 M |
Jun 12 2007 | DOVP | Euthymics Bioscien ... | POLYGON GLOBAL OPPORTUNITIES M ... | 10% Owner | Option Exercise | C | 0.00 | 64,000 | 0 | 12,225,672 | |
Jun 12 2007 | DOVP | Euthymics Bioscien ... | POLYGON GLOBAL OPPORTUNITIES M ... | 10% Owner | Buy | C | 0.00 | 12,225,672 | 0 | 12,225,672 | 0 to 12.2 M |
Jan 23 2007 | DOVP | Euthymics Bioscien ... | Stern Warren Charles | Sr. V.P. Drug Devel ... | Option Exercise | A | 0.39 | 50,000 | 19,500 | 460,000 | |
Jan 23 2007 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | President and CFO | Option Exercise | A | 0.39 | 75,000 | 29,250 | 799,500 | |
Jan 23 2007 | DOVP | Euthymics Bioscien ... | Skolnick Phil | Executive VP and CS ... | Option Exercise | A | 0.39 | 50,000 | 19,500 | 790,000 | |
Jul 10 2006 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Buy | P | 2.32 | 45,000 | 104,400 | 45,000 | 0 to 45 K |
Jul 05 2006 | DOVP | Euthymics Bioscien ... | Duncan Barbara Gayle | President and CFO | Option Exercise | A | 2.12 | 350,000 | 742,000 | 724,500 | |
Jul 05 2006 | DOVP | Euthymics Bioscien ... | Stern Warren Charles | Sr. V.P. Drug Devel ... | Option Exercise | A | 2.12 | 75,000 | 159,000 | 410,000 | |
Jul 05 2006 | DOVP | Euthymics Bioscien ... | Skolnick Phil | Executive VP and CS ... | Option Exercise | A | 2.12 | 350,000 | 742,000 | 740,000 | |
Jun 30 2006 | DOVP | Euthymics Bioscien ... | Myers Scott Dunseth | Senior Vice Preside ... | Option Exercise | A | 2.08 | 50,000 | 104,000 | 335,000 | |
May 26 2006 | DOVP | Euthymics Bioscien ... | Myers Scott Dunseth | Senior Vice Preside ... | Buy | P | 2.69 | 5,000 | 13,450 | 10,000 | 5 K to 10 K (+100.00 %) |
May 26 2006 | DOVP | Euthymics Bioscien ... | Myers Scott Dunseth | Senior Vice Preside ... | Buy | P | 2.69 | 5,000 | 13,450 | 5,000 | 0 to 5 K |
May 24 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 24 2006 | DOVP | Euthymics Bioscien ... | VAN RIPER DANIEL S | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 24 2006 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Grant | A | 0.00 | 5,000 | 0 | 55,200 | 50.2 K to 55.2 K (+9.96 %) |
May 24 2006 | DOVP | Euthymics Bioscien ... | Ashe Patrick | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 23 2006 | DOVP | Euthymics Bioscien ... | Podlesak Dennis | Director | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
May 18 2006 | DOVP | Euthymics Bioscien ... | ORBIMED ADVISORS LLC | Director | Sell | S | 3.25 | 258,858 | 841,289 | 258,000 | 516.9 K to 258 K (-50.08 %) |
May 18 2006 | DOVP | Euthymics Bioscien ... | ORBIMED ADVISORS LLC | Director | Sell | S | 3.25 | 11,422 | 37,122 | 11,400 | 22.8 K to 11.4 K (-50.05 %) |
May 18 2006 | DOVP | Euthymics Bioscien ... | ORBIMED ADVISORS LLC | Director | Sell | S | 3.25 | 547,491 | 1,779,346 | 548,000 | 1.1 M to 548 K (-49.98 %) |
Apr 05 2006 | DOVP | Euthymics Bioscien ... | Skolnick Phil | Sr. V.P. Research, ... | Option Exercise | C | 2.78 | 5,000 | 13,900 | 390,000 | |
Apr 05 2006 | DOVP | Euthymics Bioscien ... | Skolnick Phil | Sr. V.P. Research, ... | Sell | S | 16.05 | 5,000 | 80,260 | 0 | 5 K to 0 (-100.00 %) |
Apr 05 2006 | DOVP | Euthymics Bioscien ... | Skolnick Phil | Sr. V.P. Research, ... | Buy | C | 2.78 | 5,000 | 13,900 | 5,000 | 0 to 5 K |
Mar 15 2006 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Option Exercise | C | 2.78 | 12,400 | 34,472 | 89,300 | |
Mar 15 2006 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Sell | S | 17.43 | 12,400 | 216,085 | 50,200 | 62.6 K to 50.2 K (-19.81 %) |
Mar 15 2006 | DOVP | Euthymics Bioscien ... | HOROVITZ ZOLA P | Director | Buy | C | 2.78 | 12,400 | 34,472 | 62,600 | 50.2 K to 62.6 K (+24.70 %) |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Option Exercise | C | 2.78 | 10,000 | 27,800 | 425,000 | |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Sell | S | 19.42 | 2,000 | 38,840 | 0 | 2 K to 0 (-100.00 %) |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Sell | S | 19.43 | 1,000 | 19,430 | 2,000 | 3 K to 2 K (-33.33 %) |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Sell | S | 19.40 | 2,000 | 38,800 | 3,000 | 5 K to 3 K (-40.00 %) |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Sell | S | 19.30 | 5,000 | 96,500 | 5,000 | 10 K to 5 K (-50.00 %) |
Mar 02 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Buy | C | 2.78 | 10,000 | 27,800 | 10,000 | 0 to 10 K |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Option Exercise | C | 4.01 | 25,000 | 100,250 | 374,500 | |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Option Exercise | C | 4.01 | 20,000 | 80,200 | 399,500 | |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 19.00 | 21,700 | 412,300 | 25,000 | 46.7 K to 25 K (-46.47 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 19.01 | 1,900 | 36,119 | 46,700 | 48.6 K to 46.7 K (-3.91 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 19.02 | 1,400 | 26,628 | 48,600 | 50 K to 48.6 K (-2.80 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Buy | C | 4.01 | 25,000 | 100,250 | 50,000 | 25 K to 50 K (+100.00 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 18.00 | 20,000 | 360,000 | 25,000 | 45 K to 25 K (-44.44 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Buy | C | 4.01 | 20,000 | 80,200 | 45,000 | 25 K to 45 K (+80.00 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Option Exercise | C | 2.78 | 30,000 | 83,400 | 405,000 | |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Sell | S | 18.05 | 30,000 | 541,500 | 0 | 30 K to 0 (-100.00 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CSO | Buy | C | 2.78 | 30,000 | 83,400 | 30,000 | 0 to 30 K |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.00 | 316,200 | 5,691,600 | 439,200 | 755.4 K to 439.2 K (-41.86 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.01 | 200 | 3,602 | 755,400 | 755.6 K to 755.4 K (-0.03 %) |
Feb 13 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 18.10 | 300 | 5,430 | 755,600 | 755.9 K to 755.6 K (-0.04 %) |
Feb 09 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP and CFO | Option Exercise | A | 17.61 | 15,000 | 264,150 | 419,500 | |
Feb 09 2006 | DOVP | Euthymics Bioscien ... | Hudson Leslie | CEO and President | Option Exercise | A | 17.61 | 50,000 | 880,500 | 275,000 | |
Feb 09 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Drug Devel ... | Option Exercise | A | 17.61 | 25,000 | 440,250 | 335,000 | |
Feb 09 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Option Exercise | A | 17.61 | 15,000 | 264,150 | 435,000 | |
Feb 03 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | S.V.P. & CSO | Option Exercise | C | 2.78 | 5,000 | 13,900 | 420,000 | |
Feb 03 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | S.V.P. & CSO | Sell | S | 15.82 | 5,000 | 79,100 | 0 | 5 K to 0 (-100.00 %) |
Feb 03 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | S.V.P. & CSO | Buy | C | 2.78 | 5,000 | 13,900 | 5,000 | 0 to 5 K |
Jan 12 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & C.S.O. | Option Exercise | C | 2.78 | 10,000 | 27,800 | 425,000 | |
Jan 12 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & C.S.O. | Sell | S | 15.90 | 5,000 | 79,500 | 0 | 5 K to 0 (-100.00 %) |
Jan 12 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & C.S.O. | Sell | S | 15.82 | 5,000 | 79,100 | 5,000 | 10 K to 5 K (-50.00 %) |
Jan 12 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. & C.S.O. | Buy | C | 2.78 | 10,000 | 27,800 | 10,000 | 0 to 10 K |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Option Exercise | C | 4.01 | 20,000 | 80,200 | 404,500 | |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.00 | 1,600 | 27,200 | 0 | 1.6 K to 0 (-100.00 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.01 | 100 | 1,701 | 1,600 | 1.7 K to 1.6 K (-5.88 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.02 | 400 | 6,808 | 1,700 | 2.1 K to 1.7 K (-19.05 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.03 | 100 | 1,703 | 2,100 | 2.2 K to 2.1 K (-4.55 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.05 | 2,300 | 39,215 | 2,200 | 4.5 K to 2.2 K (-51.11 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.10 | 2,200 | 37,620 | 4,500 | 6.7 K to 4.5 K (-32.84 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.11 | 1,000 | 17,110 | 6,700 | 7.7 K to 6.7 K (-12.99 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.12 | 2,300 | 39,376 | 7,700 | 10 K to 7.7 K (-23.00 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.13 | 600 | 10,278 | 10,000 | 10.6 K to 10 K (-5.66 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.14 | 1,400 | 23,996 | 10,600 | 12 K to 10.6 K (-11.67 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.15 | 1,000 | 17,150 | 12,000 | 13 K to 12 K (-7.69 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.16 | 1,600 | 27,456 | 13,000 | 14.6 K to 13 K (-10.96 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.17 | 200 | 3,434 | 14,600 | 14.8 K to 14.6 K (-1.35 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.18 | 100 | 1,718 | 14,800 | 14.9 K to 14.8 K (-0.67 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.19 | 1,500 | 25,785 | 14,900 | 16.4 K to 14.9 K (-9.15 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.20 | 2,600 | 44,720 | 16,400 | 19 K to 16.4 K (-13.68 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Sell | S | 17.21 | 1,000 | 17,210 | 19,000 | 20 K to 19 K (-5.00 %) |
Feb 07 2006 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | SVP & CFO | Buy | C | 4.01 | 20,000 | 80,200 | 20,000 | 0 to 20 K |
Nov 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Option Exercise | C | 2.78 | 5,000 | 13,900 | 435,000 | |
Nov 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Sell | S | 15.82 | 5,000 | 79,100 | 0 | 5 K to 0 (-100.00 %) |
Nov 09 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Buy | C | 2.78 | 5,000 | 13,900 | 5,000 | 0 to 5 K |
Nov 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.27 | 83,300 | 1,271,991 | 755,900 | 839.2 K to 755.9 K (-9.93 %) |
Nov 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.07 | 79,500 | 1,197,970 | 839,200 | 918.7 K to 839.2 K (-8.65 %) |
Nov 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 15.27 | 37,200 | 567,951 | 918,700 | 955.9 K to 918.7 K (-3.89 %) |
Oct 21 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Option Exercise | C | 2.47 | 10,500 | 25,935 | 101,700 | |
Oct 21 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Sell | S | 14.52 | 10,500 | 152,500 | 50,200 | 60.7 K to 50.2 K (-17.30 %) |
Oct 21 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Director | Buy | C | 2.47 | 10,500 | 25,935 | 60,700 | 50.2 K to 60.7 K (+20.92 %) |
Oct 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Option Exercise | C | 2.78 | 5,000 | 13,900 | 440,000 | |
Oct 04 2005 | DOVP | Euthymics Bioscien ... | DOV PHARMACEUTICAL INC | Sr. V.P. Research, ... | Sell | S | 16.88 | 5,000 | 84,400 | 0 | 5 K to 0 (-100.00 %) |